Found: 5000
Select item for more details and to access through your institution.
Pyoderma Gangrenosum-like Ulcers Associated Granulomatosis with Polyangiitis.
- Published in:
- Case Reports in Clinical Practice, 2024, v. 9, n. 1, p. 6
- By:
- Publication type:
- Article
Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell–depleting antibodies: reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients with Progressive and Symptomatic Fibrosing Mediastinitis.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 11, p. 1533, doi. 10.1513/AnnalsATS.202405-533OC
- By:
- Publication type:
- Article
Púrpura trombótica trombocitopénica. Presentación de casos y discusión.
- Published in:
- MedUNAB, 2008, v. 11, n. 2, p. 176
- By:
- Publication type:
- Article
Rituximab-Induced Acute ST Elevation Myocardial Infarction.
- Published in:
- Ochsner Journal, 2015, v. 15, n. 2, p. 187
- By:
- Publication type:
- Article
Long-Term Responses to Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia.
- Published in:
- 2007
- Publication type:
- Abstract
Rituximab Effective in Treating Chronic Graft-vs-Host Disease.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 5, p. 475
- Publication type:
- Article
Rituxan Plus CHOP Approved for Diffuse Large B-Cell Lymphoma.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 3, p. 264
- Publication type:
- Article
Successful implementation of rituximab in patients with severe refractory forms of granulomatosis with polyangiitis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Prikaz bolesnika sa dugotrajnom remisijom reumatoidnog artritisa posle jednog ciklusa rituksimaba.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2012, v. 69, n. 1, p. 78
- By:
- Publication type:
- Article
Effectiveness and safety analysis of rituximab in 146 Indian pemphigus patients: A retrospective single-center review of up to 68 months follow-up.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Primary cutaneous marginal zone B-cell lymphoma of vulva in a pregnant woman.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Low-dose rituximab as an adjuvant therapy in pemphigus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Author reply: Biologics or biosimilars: What is the difference?
- Published in:
- 2016
- By:
- Publication type:
- Letter
Biologics or biosimilars: What is the difference?
- Published in:
- 2016
- By:
- Publication type:
- Letter
Clinical efficacy of rituximab in the treatment of pemphigus: A retrospective study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The controversy of hepatitis C and rituximab: A multidisciplinary dilemma with implications for patients with pemphigus.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Use of rituximab in pemphigus patients with chronic viral hepatitis: Report of three cases.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2014, v. 80, n. 4, p. 300, doi. 10.4103/0378-6323.136832
- By:
- Publication type:
- Article
Pemphigus occurring at tuberculin injection site: Role of cytokines in acantholysis.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2013, v. 79, n. 4, p. 539, doi. 10.4103/0378-6323.113102
- By:
- Publication type:
- Article
Rituximab in pemphigus.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Childhood pemphigus vulgaris successfully treated with rituximab.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2012, v. 78, n. 5, p. 632, doi. 10.4103/0378-6323.100587
- By:
- Publication type:
- Article
Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Tratamiento de la encefalopatía mioclónica de la infancia (síndrome de Kinsbourne) con metotrexate y gammaglobulina endovenosa.
- Published in:
- Acta Pediatrica de Mexico, 2013, v. 34, n. 6, p. 370
- By:
- Publication type:
- Article
HLH and TET2 Mutation Presenting after First Cycle of CLL Treatment.
- Published in:
- Clinical Medicine & Research, 2023, v. 21, n. 3, p. 155, doi. 10.3121/cmr.2023.1804
- By:
- Publication type:
- Article
ADAMTS13 Deficiency and Thrombotic Thrombocytopenic Purpura Associated with Trimethoprim-Sulfamethoxazole.
- Published in:
- Clinical Medicine & Research, 2013, v. 11, n. 2, p. 86, doi. 10.3121/cmr.2012.1105
- By:
- Publication type:
- Article
Elucidating chemical and disulfide heterogeneities in rituximab using reduced and non‐reduced peptide mapping.
- Published in:
- Journal of Separation Science, 2022, v. 45, n. 15, p. 2887, doi. 10.1002/jssc.202200290
- By:
- Publication type:
- Article
Quantitative Biodetection of Anticancer Drug Rituxan with DNA Biosensor Modified PAMAM Dendrimer/Reduced Graphene Oxide Nanocomposite.
- Published in:
- Electroanalysis, 2018, v. 30, n. 8, p. 1651, doi. 10.1002/elan.201800014
- By:
- Publication type:
- Article
In Situ Evaluation of the Anticancer Antibody Rituximab-dsDNA Interaction Using a DNA-Electrochemical Biosensor.
- Published in:
- Electroanalysis, 2014, v. 26, n. 6, p. 1304, doi. 10.1002/elan.201300488
- By:
- Publication type:
- Article
Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B‐Cell Lymphoma Therapy.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 7, p. 3647, doi. 10.1002/ange.202005934
- By:
- Publication type:
- Article
Peptide‐Directed DNA‐Templated Protein Labelling for The Assembly of a Pseudo‐IgM.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 27, p. 9166, doi. 10.1002/ange.201903134
- By:
- Publication type:
- Article
Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 53, doi. 10.1111/bjh.15768
- By:
- Publication type:
- Article
Preparation and preliminary bioevaluation studies of <sup>68</sup>Ga‐NOTA‐rituximab fragments as radioimmunoscintigraphic agents for non‐Hodgkin lymphoma.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 12, p. 850, doi. 10.1002/jlcr.3803
- By:
- Publication type:
- Article
Preparation of clinical-scale <sup>177</sup>Lu-Rituximab: Optimization of protocols for conjugation, radiolabeling, and freeze-dried kit formulation.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2017, v. 60, n. 5, p. 234, doi. 10.1002/jlcr.3493
- By:
- Publication type:
- Article
Radiolabelling rituximab with <sup>99m</sup>Tc in three steps procedure.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2015, v. 58, n. 7, p. 274, doi. 10.1002/jlcr.3283
- By:
- Publication type:
- Article
Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2024, v. 485, n. 2, p. 307, doi. 10.1007/s00428-023-03584-9
- By:
- Publication type:
- Article
Correction to: Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2024, v. 484, n. 4, p. 657, doi. 10.1007/s00428-024-03774-z
- By:
- Publication type:
- Article
IgG4-related sclerosing thyroiditis (Riedel-Struma): a review of clinicopathological features and management.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 2, p. 133, doi. 10.1007/s00428-023-03561-2
- By:
- Publication type:
- Article
ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2021, v. 478, n. 4, p. 779, doi. 10.1007/s00428-020-02937-y
- By:
- Publication type:
- Article
Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The broad and challenging landscape of extranodal lymphoproliferations.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Two cases of phenotypic switch of primary cutaneous T cell lymphoma after treatment with an aggressive course and review of the literature.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2311, doi. 10.1007/s00432-022-04381-8
- By:
- Publication type:
- Article
Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 5, p. 1883, doi. 10.1007/s00432-022-04155-2
- By:
- Publication type:
- Article
Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 1, p. 129, doi. 10.1007/s00432-018-2772-8
- By:
- Publication type:
- Article
Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 2, p. 379, doi. 10.1007/s00432-015-2026-y
- By:
- Publication type:
- Article
Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 9, p. 1689, doi. 10.1007/s00432-015-1963-9
- By:
- Publication type:
- Article